Docgo Inc (DCGO)

$3.74

+0.19

(+5.35%)▲

Market is closed - opens 7 PM, 29 Jul 2024

Performance

  • $3.58
    $3.74
    $3.74
    downward going graph

    4.41%

    Downside

    Day's Volatility :4.41%

    Upside

    0.0%

    downward going graph
  • $2.75
    $10.82
    $3.74
    downward going graph

    26.47%

    Downside

    52 Weeks Volatility :74.58%

    Upside

    65.43%

    downward going graph

Returns

PeriodDocgo IncSector (Health Care)Index (Russel 2000)
3 Months
-1.66%
6.5%
0.0%
6 Months
0.28%
7.1%
0.0%
1 Year
-58.24%
9.8%
0.0%
3 Years
-52.67%
14.2%
-20.2%

Highlights

Market Capitalization
330.1M
Book Value
$3.02
Earnings Per Share (EPS)
0.19
PE Ratio
17.11
Wall Street Target Price
7.07
Profit Margin
3.06%
Operating Margin TTM
8.27%
Return On Assets TTM
5.3%
Return On Equity TTM
8.2%
Revenue TTM
703.4M
Revenue Per Share TTM
6.78
Quarterly Revenue Growth YOY
70.0%
Gross Profit TTM
154.7M
EBITDA
55.1M
Diluted Eps TTM
0.19
Quarterly Earnings Growth YOY
-0.16
EPS Estimate Current Year
0.29
EPS Estimate Next Year
0.15
EPS Estimate Current Quarter
0.08
EPS Estimate Next Quarter
0.08

Analyst Recommendation

Buy
    92%Buy
    7%Hold
    0
    0%Sell
Based on 13 Wall street analysts offering stock ratings for Docgo Inc(by analysts ranked 0 to 5 stars)
Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
12
12
12
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 89.04%

Current $3.74
Target $7.07

Company Financials

FY19Y/Y Change
Revenue
48.3M
-
Net Income
-21.2M
-
Net Profit Margin
-43.97%
-
FY20Y/Y Change
Revenue
94.1M
↑ 94.81%
Net Income
-14.8M
↓ 30.32%
Net Profit Margin
-15.73%
↑ 28.24%
FY21Y/Y Change
Revenue
318.7M
↑ 238.74%
Net Income
23.7M
↓ 260.44%
Net Profit Margin
7.45%
↑ 23.18%
FY22Y/Y Change
Revenue
440.5M
↑ 38.21%
Net Income
34.6M
↑ 45.66%
Net Profit Margin
7.85%
↑ 0.4%
FY23Y/Y Change
Revenue
624.3M
↑ 41.72%
Net Income
6.9M
↓ 80.17%
Net Profit Margin
1.1%
↓ 6.75%
Q4 FY22Q/Q Change
Revenue
108.8M
↑ 4.28%
Net Income
8.1M
↑ 226.97%
Net Profit Margin
7.41%
↑ 5.05%
Q1 FY23Q/Q Change
Revenue
113.0M
↑ 3.88%
Net Income
-3.5M
↓ 142.97%
Net Profit Margin
-3.07%
↓ 10.48%
Q2 FY23Q/Q Change
Revenue
125.5M
↑ 11.05%
Net Income
-2.0M
↓ 41.97%
Net Profit Margin
-1.6%
↑ 1.47%
Q3 FY23Q/Q Change
Revenue
186.6M
↑ 48.66%
Net Income
4.8M
↓ 336.91%
Net Profit Margin
2.55%
↑ 4.15%
Q4 FY23Q/Q Change
Revenue
199.2M
↑ 6.8%
Net Income
7.6M
↑ 58.88%
Net Profit Margin
3.8%
↑ 1.25%
Q1 FY24Q/Q Change
Revenue
192.1M
↓ 3.59%
Net Income
11.2M
↑ 48.31%
Net Profit Margin
5.84%
↑ 2.04%
FY19Y/Y Change
Total Assets
101.0M
-
Total Liabilities
21.6M
-
FY20Y/Y Change
Total Assets
100.2M
↓ 0.78%
Total Liabilities
33.2M
↑ 53.81%
FY21Y/Y Change
Total Assets
309.6M
↑ 209.07%
Total Liabilities
82.5M
↑ 148.44%
FY22Y/Y Change
Total Assets
393.3M
↑ 27.03%
Total Liabilities
114.4M
↑ 38.53%
FY23Y/Y Change
Total Assets
490.5M
↑ 24.71%
Total Liabilities
185.3M
↑ 62.03%
Q4 FY22Q/Q Change
Total Assets
393.3M
↑ 10.5%
Total Liabilities
114.4M
↑ 34.39%
Q1 FY23Q/Q Change
Total Assets
407.5M
↑ 3.63%
Total Liabilities
123.6M
↑ 8.11%
Q2 FY23Q/Q Change
Total Assets
390.3M
↓ 4.23%
Total Liabilities
106.4M
↓ 13.91%
Q3 FY23Q/Q Change
Total Assets
419.8M
↑ 7.56%
Total Liabilities
128.2M
↑ 20.49%
Q4 FY23Q/Q Change
Total Assets
490.5T
↑ 1.168342222E8%
Total Liabilities
185.3T
↑ 1.4448910352E8%
Q1 FY24Q/Q Change
Total Assets
490.7M
↓ 100.0%
Total Liabilities
175.6M
↓ 100.0%
FY19Y/Y Change
Operating Cash Flow
-14.2M
-
Investing Cash Flow
-3.0M
-
Financing Cash Flow
56.3M
-
FY20Y/Y Change
Operating Cash Flow
-10.7M
↓ 25.0%
Investing Cash Flow
-6.0M
↑ 103.28%
Financing Cash Flow
-812.1K
↓ 101.44%
FY21Y/Y Change
Operating Cash Flow
-1.9M
↓ 81.72%
Investing Cash Flow
-8.6M
↑ 42.2%
Financing Cash Flow
155.2M
↓ 19211.91%
FY22Y/Y Change
Operating Cash Flow
28.9M
↓ 1582.47%
Investing Cash Flow
-38.4M
↑ 347.63%
Financing Cash Flow
-6.2M
↓ 103.98%
Q4 FY22Q/Q Change
Operating Cash Flow
-8.7M
↓ 217.75%
Investing Cash Flow
-654.0K
↓ 98.18%
Financing Cash Flow
-6.9M
↑ 1473.19%
Q1 FY23Q/Q Change
Operating Cash Flow
-23.1M
↑ 164.58%
Investing Cash Flow
-1.7M
↑ 158.33%
Financing Cash Flow
-12.0M
↑ 74.07%
Q2 FY23Q/Q Change
Operating Cash Flow
10.7M
↓ 146.25%
Investing Cash Flow
-23.7M
↑ 1304.44%
Financing Cash Flow
8.8M
↓ 173.3%

Technicals Summary

Sell

Neutral

Buy

Docgo Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Docgo Inc
Docgo Inc
15.64%
0.28%
-58.24%
-52.67%
-52.67%
Fresenius Medical Care Ag
Fresenius Medical Care Ag
6.75%
1.59%
-22.77%
-49.63%
-45.76%
Hca Holdings, Inc.
Hca Holdings, Inc.
3.62%
24.47%
25.02%
43.55%
143.2%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
10.35%
80.65%
95.1%
108.93%
580.33%
Universal Health Services Inc.
Universal Health Services Inc.
8.08%
30.09%
44.94%
32.59%
34.96%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
0.24%
32.97%
40.81%
19.01%
139.9%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Docgo Inc
Docgo Inc
17.11
17.11
NA
0.29
0.08
0.05
NA
3.02
Fresenius Medical Care Ag
Fresenius Medical Care Ag
22.58
22.58
0.39
1.5
0.05
0.03
0.03
47.4
Hca Holdings, Inc.
Hca Holdings, Inc.
16.16
16.16
1.44
21.86
0.74
0.11
0.01
-6.06
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
5.46
5.46
1.74
8.98
0.54
0.07
NA
16.09
Universal Health Services Inc.
Universal Health Services Inc.
15.8
15.8
1.87
13.79
0.13
0.06
0.0
93.48
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
16.31
16.31
1.16
9.32
0.43
0.06
NA
10.56
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Docgo Inc
Docgo Inc
Buy
$330.1M
-52.67%
17.11
3.06%
Fresenius Medical Care Ag
Fresenius Medical Care Ag
Hold
$11.9B
-45.76%
22.58
2.48%
Hca Holdings, Inc.
Hca Holdings, Inc.
Buy
$90.1B
143.2%
16.16
8.4%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
Buy
$14.6B
580.33%
5.46
12.54%
Universal Health Services Inc.
Universal Health Services Inc.
Hold
$12.4B
34.96%
15.8
5.57%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
Hold
$12.6B
139.9%
16.31
6.61%

Insights on Docgo Inc

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 199.24M → 192.08M (in $), with an average decrease of 3.6% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 5 quarters, -3.46M → 11.22M (in $), with an average increase of 71.0% per quarter

  • Vs THC

    In the last 1 year, Tenet Healthcare Corp.  has given 95.1% return, outperforming this stock by 153.3%

Institutional Holdings

  • BlackRock Inc

    6.11%

  • Deerfield Management Co

    5.03%

  • Vanguard Group Inc

    4.78%

  • WCM Investment Management

    2.59%

  • State Street Corporation

    2.06%

  • S Squared Technology, LLC

    1.91%

Company Information

DocGo is a leading provider of mobile medical services and transportation in 26 US States and in the United Kingdom.

Organization
Docgo Inc
Employees
2915
CEO
Mr. Lee Bienstock
Industry
Transportation

Discover More

FAQs